196 related articles for article (PubMed ID: 19630105)
21. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae.
Lowry PW; Weaver AL; Tremaine WJ; Sandborn WJ
Inflamm Bowel Dis; 1999 Nov; 5(4):239-45. PubMed ID: 10579116
[TBL] [Abstract][Full Text] [Related]
22. Does Perianal Disease Influence the Efficacy of Combination Therapy in Crohn's Disease?
de Sousa Magalhães R; Xavier S; Cúrdia Gonçalves T; Dias de Castro F; Rosa B; Moreira MJ; Cotter J
Dig Dis; 2021; 39(4):417-428. PubMed ID: 33197911
[TBL] [Abstract][Full Text] [Related]
23. Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patients.
Gisbert JP; Niño P; Cara C; Rodrigo L
Aliment Pharmacol Ther; 2008 Jul; 28(2):228-38. PubMed ID: 18485129
[TBL] [Abstract][Full Text] [Related]
24. Anal lesions: any significant prognosis in Crohn's disease?
Siproudhis L; Mortaji A; Mary JY; Juguet F; Bretagne JF; Gosselin M
Eur J Gastroenterol Hepatol; 1997 Mar; 9(3):239-43. PubMed ID: 9096423
[TBL] [Abstract][Full Text] [Related]
25. Response to medical treatment in patients with Crohn's disease: the role of NOD2/CRAD15, disease phenotype, and age of diagnosis.
Weiss B; Lebowitz O; Fidder HH; Maza I; Levine A; Shaoul R; Reif S; Bujanover Y; Karban A
Dig Dis Sci; 2010 Jun; 55(6):1674-80. PubMed ID: 19693669
[TBL] [Abstract][Full Text] [Related]
26. A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease.
Reinisch W; Panés J; Lémann M; Schreiber S; Feagan B; Schmidt S; Sturniolo GC; Mikhailova T; Alexeeva O; Sanna L; Haas T; Korom S; Mayer H
Am J Gastroenterol; 2008 Sep; 103(9):2284-92. PubMed ID: 18671816
[TBL] [Abstract][Full Text] [Related]
27. Methotrexate for induction of remission in refractory Crohn's disease.
McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease.
Hassard PV; Vasiliauskas EA; Kam LY; Targan SR; Abreu MT
Inflamm Bowel Dis; 2000 Feb; 6(1):16-20. PubMed ID: 10701145
[TBL] [Abstract][Full Text] [Related]
29. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease.
Cuffari C; Dassopoulos T; Turnbough L; Thompson RE; Bayless TM
Clin Gastroenterol Hepatol; 2004 May; 2(5):410-7. PubMed ID: 15118980
[TBL] [Abstract][Full Text] [Related]
30. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
[TBL] [Abstract][Full Text] [Related]
31. Role of immunosuppressives in special situations: perianal disease and postoperative period.
Ghosh S; Iacucci M
Dig Dis; 2014; 32 Suppl 1():92-5. PubMed ID: 25531359
[TBL] [Abstract][Full Text] [Related]
32. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
Papay P; Reinisch W; Ho E; Gratzer C; Lissner D; Herkner H; Riss S; Dejaco C; Miehsler W; Vogelsang H; Novacek G
Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
[TBL] [Abstract][Full Text] [Related]
33. Azathioprine is more effective than mesalazine at preventing recurrent bowel obstruction in patients with ileocecal Crohn's disease.
Vidigal FM; de Souza GS; Chebli LA; da Rocha Ribeiro TC; Furtado MC; Castro AC; Pinto AL; do Valle Pinheiro B; de Lima Pace FH; Machado de Oliveira J; de Oliveira Zanini KA; Gaburri PD; Zanini A; Ribeiro LC; Chebli JM
Med Sci Monit; 2014 Nov; 20():2165-70. PubMed ID: 25370731
[TBL] [Abstract][Full Text] [Related]
34. [Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary].
Kiss LS; Szamosi T; Molnár T; Miheller P; Lakatos L; Vincze A; Palatka K; Bartha Z; Gasztonyi B; Salamon A; Horváth G; Tóth GT; Farkas K; Banai J; Tulassay Z; Nagy F; Szenes M; Veres G; Lovász BD; Végh Z; Golovics PA; Szathmári M; Papp M; Lakatos PL
Orv Hetil; 2011 Sep; 152(36):1433-42. PubMed ID: 21865144
[TBL] [Abstract][Full Text] [Related]
35. Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease.
Vegh Z; Kurti Z; Gonczi L; Golovics PA; Lovasz BD; Szita I; Balogh M; Pandur T; Vavricka SR; Rogler G; Lakatos L; Lakatos PL
Scand J Gastroenterol; 2016 Jul; 51(7):848-54. PubMed ID: 26880133
[TBL] [Abstract][Full Text] [Related]
36. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype.
Tarrant KM; Barclay ML; Frampton CM; Gearry RB
Am J Gastroenterol; 2008 Dec; 103(12):3082-93. PubMed ID: 19086959
[TBL] [Abstract][Full Text] [Related]
37. Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course.
Harris RE; Aloi M; de Ridder L; Croft NM; Koletzko S; Levine A; Turner D; Veereman G; Neyt M; Bigot L; Ruemmele FM; Russell RK;
BMJ Open; 2020 Jul; 10(7):e034892. PubMed ID: 32611737
[TBL] [Abstract][Full Text] [Related]
38. Infliximab plus azathioprine is more effective than azathioprine alone in achieving mucosal healing in pediatric patients with Crohn's disease.
Melek J; Štanclová M; Dědek P; Malý J; Bayer M; Pozler O; Bureš J
J Dig Dis; 2020 Dec; 21(12):705-710. PubMed ID: 32755026
[TBL] [Abstract][Full Text] [Related]
39. [Azathioprine and mesalazine in the prevention of postsurgical recurrence of Crohn's disease: a retrospective study].
Domènech E; Scala L; Bernal I; García-Planella E; Casalots A; Piñol M; Esteve-Comas M; Cabré E; Boix J; Gassull MA
Gastroenterol Hepatol; 2004 Dec; 27(10):563-7. PubMed ID: 15574279
[TBL] [Abstract][Full Text] [Related]
40. Low-dose azathioprine is effective in maintaining remission among Chinese patients with Crohn's disease.
Wu J; Gao Y; Yang C; Yang X; Li X; Xiao S
J Transl Med; 2013 Sep; 11():235. PubMed ID: 24070341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
